INVA Q1 2018 Earnings — Innoviva, Inc. Revenue & Financial Results | Market Cap Arena

INVAInnoviva, Inc.

$1B

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$52M+29.4% YoY

Gross Profit

$52M100.0% margin

Operating Income

$41M77.7% margin

Net Income

$30M56.5% margin

EPS (Diluted)

$0.27

QoQ Revenue Growth

-24.7%

Cash Flow

Operating Cash Flow

$50M

Free Cash Flow

$50M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$277M

Total Liabilities

$489M

Stockholders' Equity

-$214M

Cash & Equivalents

$27M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$52M	$40M	+29.4%
Gross Profit	$52M	$40M	+30.5%
Operating Income	$41M	$29M	+38.7%
Net Income	$30M	$17M	+75.6%